drugset / Trial / NCT01043224

A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris

NCT01043224

Phase 1 Completed 24 enrolled LEO Pharma
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this trial is to compare the anti-psoriatic effect of a topical combination product containing clobetasol propionate and calcipotriol in an ointment formulation to the single components in the same vehicle using a psoriasis plaque test design.

Timeline

Start
2010-01
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule Topical
Subject clobetasol propionate Small molecule Topical

Indications